HOOKIPA Pharma Inc (HOOK)
0.8364
+0.03
(+3.13%)
USD |
NASDAQ |
May 17, 16:00
0.8364
0.00 (0.00%)
After-Hours: 20:00
HOOKIPA Pharma Research and Development Expense (Quarterly): 20.17M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 20.17M |
| December 31, 2023 | 21.16M |
| September 30, 2023 | 24.62M |
| June 30, 2023 | 19.71M |
| March 31, 2023 | 20.93M |
| December 31, 2022 | 17.59M |
| September 30, 2022 | 18.29M |
| June 30, 2022 | 16.15M |
| March 31, 2022 | 16.62M |
| December 31, 2021 | 22.42M |
| September 30, 2021 | 20.70M |
| June 30, 2021 | 19.57M |
| March 31, 2021 | 20.16M |
| Date | Value |
|---|---|
| December 31, 2020 | 15.69M |
| September 30, 2020 | 16.01M |
| June 30, 2020 | 11.56M |
| March 31, 2020 | 11.53M |
| December 31, 2019 | 11.18M |
| September 30, 2019 | 11.02M |
| June 30, 2019 | 13.93M |
| March 31, 2019 | 10.18M |
| December 31, 2018 | 4.615M |
| September 30, 2018 | 6.17M |
| June 30, 2018 | 6.211M |
| March 31, 2018 | 4.969M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
11.02M
Minimum
Sep 2019
24.62M
Maximum
Sep 2023
17.45M
Average
17.94M
Median
Research and Development Expense (Quarterly) Benchmarks
| Absci Corp | 12.24M |
| NovaBay Pharmaceuticals Inc | 0.019M |
| Palatin Technologies Inc | 5.554M |
| iBio Inc | 1.535M |
| Theriva Biologics Inc | 3.459M |